Fresenius Kabi's tocilizumab biosimilar Tyenne® is the first and only tocilizumab biosimilar to be launched in Canada and is ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, and role of tocilizumab in rheumatoid arthritis (RA) are reviewed. Summary: Tocilizumab is a novel monoclonal antibody that ...

Tocilizumab is effective and safe for rheumatoid ... both as an infusion and an injection. Available data on the IL-6 receptor–targeting monoclonal antibody include those from randomized ...

Actemra is a recombinant humanized anti-IL-6R monoclonal antibody for injection. Interleukin-6 (IL-6) triggers its signaling system through binding to 80 kDa transmembrane IL-6 receptor (IL-6R).